Skip to content
Tuesday, November 17, 2026
WordBuzz

World Health Organization Sounds Concern Over Acute Lack of Obesity Medications

Under a tenth of patients that would benefit from weight-loss injections including Wegovy can access them, caution the global health agency as it issues its first advice on the drugs.

Given over a billion individuals worldwide currently classified as obese, it is calling for increased and just access to these injectable treatments.

According to projections, in excess of 2,000,000,000 are projected to be obese by 2030 if no action is taken.

"Our latest guidance acknowledges that excess weight is a lifelong illness that can be managed with comprehensive and continuous treatment," stated WHO director-general Tedros Adhanom Ghebreyesus.

Substantial prices, constrained manufacturing, and logistical bottlenecks are key hurdles to widespread access to the treatments that can aid individuals in losing considerable body mass, explains the agency.

Skinny Jab Shortage

Despite the present best projected scenario, the production of GLP-1 therapies could only cover around 100 million people – under 10% of eligible patients, per the health organization.

The recommendation calls on nations and manufacturers to expand access, through strategies including licensing agreements.

The intellectual property rights on the active ingredient – the primary component of Novo Nordisk's Wegovy – is due to expire in several nations in 2026.

How Weight-Loss Jabs Work

GLP-1 drugs imitate a natural hormone to slow digestion, curb appetite and boost satiety so people eat less.

People commonly begin shedding pounds within a few weeks of starting on the weekly injections.

Evidence indicates users may regain a significant portion after a year of stopping the drug, as their normal appetite return.

Being above a healthy weight increases your chance for experiencing health problems, including type 2 diabetes, heart disease, stroke, and certain malignancies.

Obesity impacts people in countries worldwide and was responsible for millions of deaths worldwide in 2024, according to the WHO.

The writer

Robin Lopez

Layla is a seasoned journalist with over a decade of experience in Middle Eastern affairs, specializing in economic and social developments.

WordBuzz

Type to search articles.